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Pain as a Motivator of Smoking:
Effects of Pain Induction on Smoking Urge and Behavior
Joseph W. Ditre
ABSTRACT
Tobacco smoking has been associated with the development, protraction, and
exacerbation of chronically painful conditions. Conversely, there is reason to believe that
smokers may be motivated to use tobacco as a means of coping with their pain. To date,
no controlled, experimental studies have tested for a causal relationship between pain
and smoking motivation. The primary aim of the current study was to test the hypothesis
that laboratory-induced cold-pressor pain would enhance smoking motivation, as
measured by self-reported urge to smoke and observation of immediate smoking
behavior. The effect of a smoking cue was also tested. Smokers (N = 132) were
randomly assigned to one of four conditions in this 2 (Pain Manipulation) X 2 (Smoking
Cue Manipulation) crossed factorial between-subjects design. Results indicated that
both pain induction and the presence of smoking cues increased urge ratings, and pain
induction also produced a shorter latency to smoke. The relationship between pain and
increased urge to smoke was partially mediated by pain-induced negative affect. This
study provides the first experimental evidence that situational pain can be a potent
motivator of smoking.

iv

Introduction
Despite evidence that smoking harms nearly every organ of the body, causing
premature morbidity and mortality (USDHHS, 2004), approximately 50 million adults
continue to smoke tobacco (CDC, 2005). According to the American Pain Society
(2003), over 75 million Americans are totally or partially disabled by serious pain, and
more than 50 million suffer from chronic nonmalignant pain. Pain and smoking have
been linked in both the clinical and empirical literature for decades. In fact, the
prevalence of smoking among individuals in pain is approximately double that of the
general population, indicating that more than half of chronic pain patients are smokers
(Brage & Bjerkedal, 1996; Hagg, Fritzell, & Nordwall, 2002; Jamison, Stetson, & Parris,
1991; Nuprin, 1985). The empirical literature regarding the relationship between pain
and smoking can be conceptualized as investigating either the effects of smoking on
pain (e.g., smoking causing, increasing, or inhibiting pain) or the effects of pain on
smoking (e.g., pain increasing smoking motivation), with the latter direction receiving far
less attention.
Although a causal effect has yet to be demonstrated, a copious number of mostly
cross-sectional studies provide evidence of an association between smoking and
increased prevalence and aggravation of several painful conditions, including:
musculoskeletal pain (Andersson, Ejlertsson, & Leden, 1998; Biering-Sorensen &
Thomsen, 1986; Brage & Bjerkedal, 1996; Eriksen, Brage, & Bruusgaard, 1997;
Frymoyer et al., 1980; Leino-Arjas, 1998; Lindal & Stefansson, 1996; Palmer, Syddall,
Cooper, & Coggon, 2003; Scott, Goldberg, Mayo, Stock, & Poitras, 1999), rheumatoid
1

arthritis (Albano, Santana-Sahagun, & Weisman, 2001; Harrison & Silman, 2000;
Hutchinson, Shepstone, Moots, Lear, & Lynch, 2001; Krishnan, Sokka, & Hannonen,
2003; Tuomi, Heliovaara, Palosuo, & Aho, 1990), fibromyalgia (Wolfe & Hawley, 1998;
Yunus, Arslan, & Aldag, 2002), oral pain (Al-Wahadni & Linden, 2002; Johnson & Slach,
2001; Kinane & Chestnutt, 2000; Rees & Addy, 2002; Riley, Tomar, & Gilbert, 2004;
Unell, Soderfeldt, Halling, & Birkhed, 1999; Winn, 2001), cluster headaches (Beck,
Sieber, & Trejo, 2005; Ghandour, Overpeck, Huang, Kogan, & Scheidt, 2004; Payne,
Stetson et al., 1991; Rozen, 2005; Torelli, Cologno, & Manzoni, 1999), and bodily pain in
persons with HIV infection (Patel et al., 2006; Turner et al., 2001). Research also
suggests that smoking is associated with an increased use of opioids by post-surgical
patients in pain (Creekmore, Lugo, & Weiland, 2004; Glasson, Sawyer, Lindley, &
Ginsberg, 2002; John et al., 2006; Woodside, 2000).
Conversely, several controlled experimental pain induction studies have found
immediate analgesic effects of smoking. A direct pain-inhibitory effect of nicotine has
been consistently demonstrated in animal studies (Aceto, Bagley, Dewey, Fu, & Martin,
1986; Cooley et al., 1990; Mousa, Aloyo, & Van Loon, 1988; Sahley & Berntson, 1979).
However, of 15 studies examining the influence of smoking on human pain perception,
nine (60%) reported a pain-inhibitory effect of smoking (Fertig, Pomerleau, & Sanders,
1986; Girdler et al., 2005; Jamner, Girdler, Shapiro, & Jarvik, 1998; Kanarek &
Carrington, 2004; Lane, Lefebvre, Rose, & Keefe, 1995; Nesbitt, 1973; Pauli, Rau,
Zhuang, Brody, & Birbaumer, 1993; Pomerleau, Turk, & Fertig, 1984; Silverstein, 1982),
and six failed to observe smoking-related antinociception (Jarvik, Caskey, Rose,
Herskovic, & Sadeghpour, 1989; Knott, 1990; Shiffman & Jarvik, 1984; Sult & Moss,
1986; Unrod, Kassel, & Robinson, 2004; Waller, Schalling, Levander, & Edman, 1983).
The mixed evidence for smoking-related analgesia in humans may stem from gender
2

differences, the stimuli used to induce experimental pain, smoking history, and the
possibility that the antinociceptive effects of smoking may be achieved indirectly via its
action on other mediating psychological or physiological factors (Girdler et al., 2005;
Jamner et al., 1998; Kanarek & Carrington, 2004; Pomerleau et al., 1984; Shiffman &
Jarvik, 1984; Unrod et al., 2004).
Tobacco smoking has been associated with the occurrence, protraction, and
exacerbation of chronically painful conditions. However, consistent with experimental
evidence of smoking-related analgesia, there is reason to believe that some smokers
may be motivated to use tobacco as a means of coping with their pain. Indeed,
researchers have proposed that the avoidance, relief, or both, of pain is a powerful
behavioral reinforcer that may be an important mechanism in the maintenance of
smoking (Fertig et al., 1986; Jarvik et al., 1989; Pomerleau, 1986; Silverstein, 1982). For
example, on questionnaires administered to chronic back pain patients, 57% of patients
acknowledged a need to smoke when in pain, although only 9% stated that smoking
directly affected their pain intensity (Jamison et al., 1991). Additionally, patients were at
greater risk for smoking when their pain was most severe. A more recent cross-sectional
study found that smokers who suffered from significant pain in the previous week
smoked more cigarettes per day than smokers who indicated no significant pain (Hahn,
Rayens, Kirsh, & Passik, 2006). Moreover, 18% of the respondents who had
experienced significant pain in the past week reported using cigarettes for pain relief,
compared with 4% who did not endure significant pain.
There is also evidence of a positive relationship between daily cigarette
consumption and the intensity, frequency, and duration of widespread musculoskeletal
pain (Andersson et al., 1998; Deyo & Bass, 1989; Scott et al., 1999), rheumatoid arthritis
(Saag et al., 1997), fibromyalgia (Yunus et al., 2002), and oral pain (Riley et al., 2004).
3

However, this covariance of pain and smoking may reflect either smokers’ use of
tobacco to cope with pain, the previously reviewed findings that smoking aggravates
painful conditions, or both. That is, the direction of causality is uncertain. To date,
experimental research on pain and smoking has focused almost exclusively on
tobacco’s ability to influence the subjective experience of pain. To our knowledge, there
have been no experimental investigations into the effect of pain on smoking motivation.
Thus, the primary aim of the present study was to test the hypothesis that laboratoryinduced cold-pressor pain would elicit greater reports of smoking urge and increases in
immediate smoking behavior. A secondary aim was to test the hypothesis that the
presence of smoking cues (versus neutral cues) would elicit similar increases in smoking
motivation, and we explored whether the smoking cues would interact with pain upon
these outcomes. Environmental smoking cues such as cigarettes and smoking-related
paraphernalia have been found to predict subsequent smoking behavior (Niaura,
Abrams, Demuth, Pinto, & Monti, 1989) and to elicit greater reactivity in smokers when
compared with neutral cues (Brandon, Piasecki, Quinn, & Baker, 1995). The smoking
cue manipulation was employed in the current design for two reasons. First, we were
unsure as to whether pain would be sufficient to stimulate smoking motivation in the
absence of cues signaling the availability of smoking, consistent with Lang’s (1984)
suggestion that the probability of accessing an affective state (e.g., urge to smoke) is a
function of the number of propositions that are matched to the emotion prototype.
Second, considering the lack of prior research on pain’s capacity to elicit smoking urge,
we believed that the smoking cue manipulation would serve as a useful reference point
for calibrating the magnitude of the pain manipulation effect. Therefore, pain was
induced in the presence of either smoking cues or neutral cues to determine whether
smoking cues would produce either an additive or synergistic effect. Finally, we sought
4

to examine the influence of potential moderating variables (trait-negative affect,
smoking-related outcome expectancies, catastrophizing, ethnicity, and gender) and
mediating variables (state-negative affect) in an exploratory manner.

5

Method
Participants
Newspaper advertisements and flyers were used to recruit 132 smokers (50%
female). The sample size was selected to allow for adequate power (.80) to detect
medium sized (f = .25) main effects at the two-tailed α = .05 level (Cohen, 1988).
Prospective participants were screened for the following inclusion criteria: between 18
and 65 years of age (M = 36.0; SD = 11.8), smoke at least 20 cigarettes per day (M =
23.2; SD = 6.9), and have a pre-session expired carbon monoxide (CO) concentration of
at least 8ppm (M = 23.5; SD = 11.6). Prospective participants were also screened for the
following exclusion criteria: the presence of any contraindicative medical conditions (i.e.,
acute pain, chronic pain, diabetes, epilepsy, and recent injury), and the use of
prescription medications for pain management, heart problems, or blood circulation
problems. Individuals who failed to meet all of the inclusion criteria or endorsed any of
the exclusion criteria were not permitted to participate. Participants had an average
Fagerström Test for Nicotine Dependence (Heatherton, Kozlowski, Frecker, &
Fagerstrom, 1991) score of 5.98 (SD = 2.3), indicating that participants in the current
sample were moderately to highly dependent on tobacco. The ethnic composition was
73% Caucasian, 20% African American, 5% American Indian or Alaska Native, and 2%
other or unspecified. Thirteen participants (10%) identified themselves as Hispanic or
Latino. Participants were paid a maximum of $30 for completing the entire study.
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Design
Participants were randomly assigned to one of four conditions (Pain + Smoking
Cue; Pain + Neutral Cue; No Pain + Smoking Cue; No Pain + Neutral Cue), stratified by
gender (Riley, Robinson, Wise, Myers, & Fillingim, 1998), in this 2 (Pain Manipulation) X
2 (Cue Manipulation) crossed factorial between-subjects design. Thus, 33 participants
were randomized to each experimental condition.
Measures
Smoking Status Questionnaire (SSQ). This form was used to assess smoking
status and nicotine dependence. The SSQ includes the Fagerström Test for Nicotine
Dependence, a reliable and valid measure of nicotine dependence (Heatherton et al.,
1991).
Questionnaire of Smoking Urges-Brief (QSU-Brief; Cox, Tiffany, & Christen,
2001). The QSU-Brief is a widely used 10-item urge measure that consists of two 5-item
factor-derived subscales (F1: urge to smoke for pleasure/reward, and F2: urge to smoke
for the relief of negative affect). Participants indicated how strongly they agreed or
disagreed with each item using a Likert-type scale that ranged from 1 (strongly disagree)
to 7 (strongly agree), with higher scores indicating stronger smoking urges. The QSU-B
Total demonstrated excellent internal consistency (α = .93), as did each of the two
factor-derived subscales (α = .92 and α = .89, respectively).
Visual Analogue Scale (VAS). A single-item VAS was used to assess smoking
urge at four points throughout the study (VAS1, VAS2, VAS3, and VAS4). Participants
were asked about the strength of their urge to smoke at that exact moment, and were
instructed to make a mark along a 100mm line between the phrases “No Urge At All”
and “Strongest Urge Ever.” The VAS measures of urge were not available for the first
three participants in the study.
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Smoking Consequences Questionnaire - Adult (SCQ-A; Copeland, Brandon, &
Quinn, 1995). The SCQ-A was developed and validated for use with adults and is based
on the original 50-item Smoking Consequences Questionnaire (Brandon & Baker, 1991),
a standard instrument for measuring smoking-related outcome expectancies.
Participants were administered the following three scales: Scale 1 (a 9-item measure of
expectancies for negative affect reduction), Scale 2 (a 7-item measure of expectancies
for state enhancement), and Scale 7 (a 6-item measure of expectancies related to
craving and addiction). Each of these scales demonstrated adequate internal
consistency, with Cronbach’s α = .92, .86, and .80, respectively. In addition, a new 5item scale was added to assess smokers’ expectancies that smoking would help them
cope with pain. This Pain and Smoking Expectancies (PSE) scale demonstrated
excellent reliability (α = .95).
Positive And Negative Affect Schedule (PANAS; Watson, Clark, & Tellegen,
1988). The PANAS is comprised of two orthogonal mood scales (positive and negative),
each containing 10 items. This measure was used to assess trait-affect (PANAS-W;
mood for the past week) and state-affect (PANAS – I; current mood). Participants were
asked to rate their mood on a 5-point Likert scale, ranging from “very slightly or not at all”
to “extremely.” The ratings of each mood scale were summed, with higher scores
indicating stronger affect. The positive and negative affect scales were internally
consistent, with Cronbach’s α ranging from .90 to .91 and from .82 to .87, respectively.
Pain Catastrophizing Scale (PCS; Sullivan, Bishop, & Pivik, 1995). The PCS is a
13-item instrument that asks participants to reflect on past painful experiences, and to
indicate the degree to which they have each of 13 catastrophizing thoughts or feelings
when experiencing pain (e.g., I keep thinking about how badly I want the pain to stop),
on 5-point scales. The PCS demonstrated good reliability (α = .93).
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Numerical Rating Scale (NRS; Dworkin et al., 2005). The NRS is an 11-point
numerical rating scale of pain intensity. Following pain induction, participants were asked
to circle the number that best described their pain, at its worst, since placing their hand
in the water.
Smoking behavior. As a behavioral index of smoking motivation, participants
were given an opportunity to smoke following the manipulations. Smoking was recorded
with a discrete video camera and was later independently scored by two trained raters
using a specialized computer program. Latency to smoke (time until cigarette is first lit)
was the smoking behavior of primary interest because experimental manipulations of
negative affect and anxiety have typically resulted in decreased smoking latency
(Conklin & Perkins, 2005; Payne, Schare, Levis, & Colletti, 1991; Rose, Ananda, &
Jarvik, 1983). Behavioral variables of secondary interest included: number of puffs,
mean puff duration, mean interpuff interval, and total time spent smoking.
Manipulations
Cold Pressor. The cold pressor procedure has been used in numerous studies
investigating a wide range of pain-related outcomes. This method of pain stimulation is
thought to share some subjective qualities frequently observed in clinical pain patients
because of its potential to mimic the unpleasantness experienced by individuals with
chronically painful conditions (Keogh, Hatton, & Ellery, 2000; Rainville, Feine, Bushnell,
& Duncan, 1992). All participants were told that the maximum cold-pressor tolerance
time would be limited to five minutes. Participants in the Pain (P) induction conditions
were asked to immerse their non-dominant hand into a circulating cold-water bath (0-1˚
Celsius) until they felt it was too uncomfortable to continue. Participants in the No Pain
(NP) conditions were asked to immerse their non-dominant hand into a room
temperature bath until they felt it was too uncomfortable to continue. However, these NP
9

participants were prompted to remove their hand after 100 seconds to approximate the
tolerance times of participants in the P conditions. The 100-second submersion limit for
participants in the NP conditions was derived from mean tolerance times reported in a
recent review of cold pressor methodology (Mitchell, MacDonald, & Brodie, 2004). Both
the cold and room temperature cold pressors were identical insulated cooler units
consisting of a perforated screen (to separate the water and ice) and a 12-volt bilge
pump (to circulate the water).
Smoking Cue. To test the hypothesis that the presence of smoking cues (SC) as
compared to neutral cues (NC) during and following the experience of pain would lead to
increased motivation to smoke, all participants underwent the pain manipulation and
completed post-test questionnaires with either a SC or NC in their view. The SC
consisted of participants’ own pack of cigarettes, a lighter, and an ashtray (with one
cigarette removed from their pack and placed in the ashtray). The NC consisted of
similarly placed, sized, and shaped office supplies (e.g., box of staples, roll of tape, a
staple remover, and a pencil).
Procedure
Overview. This study was conducted in two parts during one session that lasted
approximately 80 minutes. Part one consisted of screenings and baseline measures,
whereas part two included the pain manipulation (P or NP), the cue manipulation (SC or
NC), post-test measures, and observation of smoking behavior. As approved by the
university institutional review board, we employed a two-part consent process to ensure
that anticipatory anxiety related to undergoing a cold pressor task would not influence
baseline measures. Although participants were told upfront that this was a one-session,
two-part study, there was no mention of the pain manipulation until the second informed
consent was presented and explained (i.e., after baseline measures were completed).
10

This rationale was fully explained to participants before they were asked if they wanted
to proceed with the study.
Part One. To standardize smoking behavior prior to the experiment, all
participants were asked to smoke one cigarette one hour before their appointment, and
none thereafter. They were also asked to refrain from using any non-prescription pain
medications for 24 hours prior to their appointment. On arrival, participants were
reminded that this was a two-part study, and they were told that the fist informed consent
applied only to the first part of the study. After informed consent was obtained,
participants were asked how long it had been since their last cigarette, and breath CO
level was measured with a Vitalograph CO monitor (Vitalograph, Lenexa, KS). Those
who reportedly failed to follow the standardized smoking instructions or had CO levels
below 8 ppm were excused from the study (n = 9). Participants then completed baseline
measures (SSQ, QSU-Brief, VAS1, SCQ-A, PSE, PANAS-W, PANAS-I, and the PCS).
Second Informed Consent. After participants completed the baseline measures,
they were told they had already earned $15 for completing the first part of the study and
that they were under no obligation to continue with the experiment. Participants were
then informed that the second part of this study was designed to investigate their pain
threshold and tolerance, and that they would be randomly assigned to place their hand
into either a room temperature water bath or a cold water bath. Participants were further
informed that if they were assigned to place their hand in cold water, they would only be
asked to do so until they found it too uncomfortable to continue. The experimenter
described the cold pressor procedure in detail and provided rationale for conducting the
study in two parts. None of the participants declined to proceed with the study. Once the
second informed consent was obtained, the experimenter administered a second
measure of smoking urge (VAS2) to assess the influence of anticipatory anxiety on
11

smoking motivation. Participants were then randomly assigned to one of four conditions
(P + SC, P + NC, NP + SC, NP + NC), stratified by gender. Note that both experimenters
and participants were blind to condition assignment until this point.
Part Two. After participants were randomized to their respective conditions, they
were led to an experimental room consisting of a table, a chair, and both cold pressor
units, arranged in accordance with their non-dominant hand (i.e., the table was on the
side of their dominant hand and the cold pressors were on the side of their non-dominant
hand). At this point, the cue reactivity manipulation was introduced. Participants in the
SC conditions had their own cigarettes, an ashtray, and a lighter placed on the table next
to them and were told that they would be able to smoke soon. Anticipation of a smoking
opportunity has been found to enhance cue-reactivity (e.g., Juliano & Brandon, 1998;
Wertz & Sayette, 2001). Participants in the NC conditions had similarly placed, sized,
and shaped office supplies placed on the table next to them and were told nothing about
when they would be able to smoke. Once the appropriate cue was in place, participants
were again provided with the cold pressor instructions and reassured concerning the
safety of the procedure. To standardize limb temperature and reduce the chance of
alterations in vasoconstriction influencing the results, each participant first immersed
his/her non-dominant hand in the room temperature bath for two minutes. Immediately
afterward, the same hand was immersed up to 7 cm above the wrist bone into either the
cold-water bath (Pain conditions) or back into the room temperature bath (No Pain
conditions). Only at this point did participants become aware of what condition they were
in (P vs. NP). Participants were instructed to inform the experimenter when the
sensations in their hand first became painful (pain threshold) and to also indicate when
they were no longer willing or able to tolerate the pain by removing their hand (pain
tolerance). Immediately after participants in the P conditions reported reaching their pain
12

threshold, the experimenter administered a third measure of smoking urge (VAS3) to
assess craving during the experience of pain. Participants in the NP conditions were
asked to complete VAS3 approximately 10 seconds after they submerged their hand
back into the room temperature bath.
Post-Test. Once participants removed their hand from the water (pain tolerance
for the P group and 100 seconds for the NP group) they were asked to lay their nondominant hand across the cold pressor and immediately complete the post-test
measures with their dominant hand (NRS, QSU-Brief, VAS4, and PANAS-I). When these
measures were collected, participants were provided with paper towels to dry their hand.
Once the paper towels were disposed of, the experimenter either motioned to the
smoking cues by shifting them slightly (SC conditions), or replaced the neutral cues with
smoking cues that were hidden in the room (NC conditions). All participants were then
told that they were welcome to smoke as much of one cigarette as they would like, but to
please take at least one puff. The experimenter concluded by informing participants that
he/she would return in about 10 minutes. The experimenter then left the room and the
participant was videotaped smoking the cigarette. When the experimenter returned,
participants provided a second CO sample, were debriefed, and were compensated for
their time.
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Results
Baseline Measures
There were no significant differences among the four groups on baseline
measures of smoking urge, negative affect, and pain catastrophizing (all ps > .05).
Analyses did reveal unexpected group differences on the second urge measure (VAS2),
with participants in the P conditions reporting significantly greater urge to smoke than
participants in the NP conditions, F(3, 125) = 30.30, p < .01. The reason for these group
differences remains unclear, however, because both participants and experimenters
were blind to condition assignment when the measure was administered (i.e.,
randomization had not yet taken place). Accordingly, ANCOVAs were conducted in all
subsequent urge analyses to statistically control for group differences on VAS2 that
occurred prior to randomization.
Manipulation Checks: Pain Intensity and Negative Affect
As expected, participants in the P conditions reported much greater pain intensity
(M = 7.79; SE = .19) than participants in the NP conditions (M = .46; SE = .19), as
measured by the NRS, F(3, 128) = 736.65, p < .001, effect size f = 2.38. Also as
expected, participants in the P conditions reported greater state-negative affect (M =
16.86; SE = .71) than participants in the NP conditions (M = 14.47; SE = .71) following
the pain manipulation, F(3, 128) = 5.76, p = .02, f = .21.
Primary Analyses
Smoking Urge. To examine group differences on self-report measures of
smoking urge, 2 X 2 analyses of covariance were conducted, with the pain manipulation
14

(P vs. NP) and cue type (SC vs. NC) as the two fixed factors, and pre-manipulation urge
to smoke (VAS2) as the covariate. Interactions between the two fixed factors were
tested for synergistic effects. Effect sizes, indexed as f, were calculated for significant F
tests. According to Cohen (1988), f values of .10, .25, and .40 can be considered small,
medium, and large, respectively.
Analysis of overall post-test urge to smoke (QSU-Brief Total) indicated a main
effect of the pain manipulation, F(4, 124) = 18.75, p < .001, f = .39. Urge ratings were
significantly higher for participants who experienced situational pain (P) than for
participants who did not experience pain (NP). Analysis also revealed a main effect of
cue type, F(4, 124) = 4.20, p = .04, f = .18, such that urge ratings were higher when
participants were exposed to smoking cues (SC) than when exposed to neutral cues
(NC). The pain manipulation x cue type interaction was not significant (p = .55). Thus,
the effects of pain and smoking cues were additive rather than synergistic. A main effect
of the pain manipulation was also found for a secondary measure of post-test urge to
smoke (VAS4), F(4, 124) = 5.70, p = .02, f = .21. Covariate adjusted means and
standard errors for all post-test urge measures are presented in Table 1.
Smoking Behavior. Similar 2 X 2 analyses of variance were conducted, with the
pain manipulation and cue type as the two fixed factors, and measures of immediate
smoking behavior (e.g., latency to smoke, number of puffs, puff duration) as the
dependent variables. Based on the observations of two independent raters, the data for
10 participants (7.5%) were excluded from the latency analysis either because of
experimenter error (e.g., participants cued to smoke too early in the procedure) (n = 4),
or because the participant encountered a disruptive confound (e.g., broken cigarette or
lighter) (n = 6). These participants were fairly balanced across experimental conditions
with six assigned to P conditions and four assigned to NP conditions. Finally, the data
15

from two participants (one each from the P and NP conditions) were excluded as outliers
from analyses related to puffing, because the number of puffs they took exceeded three
standard deviations from the mean.
Analysis of latency to light a cigarette following the pain manipulation revealed a
main effect of pain induction, F(3, 118) = 5.73, p = .02, f = .21, with participants in the P
conditions demonstrating significantly shorter latency to smoke than participants in the
NP conditions. No significant differences in latency to smoke as a function of cue type
were found, F(3, 118) = .30, p = .59. Latency means and standard errors for each of the
four experimental conditions are presented in Table 1. Analysis of secondary measures
of smoking behavior (i.e., number of puffs, mean puff duration, mean interpuff interval,
and total time spent smoking) indicated no significant main effects (all ps > .05).
Additional Analyses
QSU-Brief Subscales. In addition to the QSU-Brief Total, the two QSU-Brief
factor-derived subscales (F1: urge to smoke for pleasure/reward, and F2: urge to smoke
for the relief of negative affect) were examined for group differences. Analyses indicated
a main effect of the pain manipulation (P vs. NP) for both QSU-Brief F1 [F(4, 124) =
15.99, p < .001, f = .12] and QSU-Brief F2 [F(4, 124) = 12.37, p = .001, f = .32], with
greater urges reported by participants who underwent pain induction. Analyses also
indicated a main effect of cue type (SC vs. NC), but only for QSU-Brief F2 [F(4, 124) =
4.61, p = .03, f = .19], with greater urges to smoke for the relief of negative affect
reported by participants in the SC conditions. There were no pain manipulation x cue
type interactions (both ps > .21).
Smoking urge during the pain manipulation. Analysis of urge ratings (VAS3)
during the pain manipulation (i.e., while the participant’s hand was still immersed in the
cold water bath) revealed a main effect for pain induction, F(3, 125) = 10.90, p = .001, f
16

= .29. As hypothesized, urge to smoke during the pain manipulation was greater for
participants in the P conditions than for participants in the NP conditions. The main effect
for cue type (SC vs. NC) did not reach significance, F(3, 125) = 3.03, p = .08. See Table
1 for means and standard errors.
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Table 1
Marginal Means (and Standard Errors) for Post-Test Measures of Smoking Motivation
No Pain Conditions

a

QSU-B T

Pain Conditions

Pain Manipulation

Cue Manipulation
NC

SC

NC

SC

NC

SC

P

NP

37.02 (1.82)

39.67 (1.81)

44.12 (1.83)

48.96 (1.89)

38.34 (1.30)

46.54 (1.33)

**

40.57 (1.28)

44.31 (1.30)

QSU-B F1

a

22.84 (0.98)

24.47 (0.97)

27.22 (0.98)

28.20 (1.01)

23.65 (0.70)

27.71 (0.71)

**

25.03 (0.69)

26.33 (0.69)

QSU-B F2

a

14.18 (1.13)

15.20 (1.12)

16.90 (1.14)

20.80 (1.18)

14.69 (0.81)

18.83 (0.83)

**

15.54 (0.80)

17.98 (0.81)

47.30 (4.66)

51.70 (4.66)

59.06 (4.74)

71.10 (4.81)

49.50 (3.30)

65.08 (3.38)

**

53.18 (3.32)

61.40 (3.35)

55.93 (3.63)

57.81 (3.60)

62.92 (3.70)

68.82 (3.77)

56.87 (2.58)

65.87 (2.65)

*

59.42 (2.56)

63.31 (2.58)

3.88 (0.69)

5.19 (0.70)

3.10 (0.69)

2.57 (0.75)

4.53 (0.49)

2.84 (0.51)

*

3.49 (0.49)

3.88 (0.52)

VAS 3

b

VAS 4

a

b

Latency

*

*

Note. NC = neutral cue conditions. SC = smoking cue conditions. P = pain induction conditions. NP = no pain induction conditions. QSU-B
T = mean scores on the total QSU-Brief measure of smoking urge administered post-pain manipulation. QSU-B F1 = mean scores on
Factor 1 of the QSU-Brief (urge to smoke for pleasure/reward). QSU-B F2 = mean scores on Factor 2 of the QSU-Brief (urge to smoke for
the relief of negative affect). VAS 3 = mean scores on a visual analogue scale of smoking urge administered during the pain manipulation.
VAS 4 = mean scores on a visual analogue scale of smoking urge administered post-pain manipulation. Latency = mean latency to light a
cigarette post-pain manipulation (in seconds).
a

Covariate (VAS2) adjusted means and standard errors. bUnadjusted means and standard errors.

*p < .05. **p < .01., for main effects of the pain and cue manipulations, respectively.
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Mediation. Mediation analyses were conducted to examine whether situational
pain indirectly enhanced smoking urge by increasing levels of state negative affect (NA).
Formal significance tests of the indirect effect of NA were conducted by means of the
Sobel test (1982) and a bootstrap approach (Efron & Tibshirani, 1993), as described by
Preacher & Hayes (2004). Results of both procedures indicated that the indirect effect of
pain induction on urge to smoke through increased NA was significantly different from
zero (p < .05). To further examine the degree of mediation, a four-step, ordinary least
squares approach was employed (Baron & Kenny, 1986). According to Baron and Kenny
(1986), if all four steps are met, the data are consistent with the hypothesis that variable
M completely mediates the X - Y relationship, and if the first three steps are met but the
fourth step is not, then partial mediation is indicated. Analyses revealed the following:
Step 1 indicated a significant total effect of pain induction on urge to smoke (ß = .43, R2
= .19, p < .001); Step 2 indicated a significant effect of pain induction on NA (ß = .21, R2
= .04, p = .02); and Step 3 indicated a significant effect of NA on urge to smoke, while
controlling for pain induction (ß = .32, sr2 = .096, p < .001). Thus, the first three steps in
establishing mediation were satisfied, supporting the results of our tests of the indirect
effect. Step 4, however, revealed that although the total effect of pain induction on
smoking urge decreased when controlling for NA, it remained significant (ß = .37, sr2 =
.129, p < .001), indicating that NA partially mediated this relationship. These results
demonstrate that pain induction and pain-induced NA, collectively, accounted for 28% of
the variance (R2 = .28) in self-reported urge to smoke. Of this, pain induction uniquely
accounted for 13%, NA uniquely accounted for 9.5%, and approximately 5.5% of the
variance was shared. Thus, NA accounted for approximately 30% of the total effect of
pain induction on urge to smoke (5.5% / 18.5%). Finally, analyses revealed no evidence
that NA mediated the effect of pain induction on latency to smoke (all ps > .11).
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Moderation. Several potential moderators of the relationship between pain and
smoking motivation (trait-negative affect, smoking-related outcome expectancies,
catastrophizing, ethnicity, and gender) were explored via interaction tests using multiple
regression (Baron & Kenny, 1986). No significant interactions were found.
Pain threshold and tolerance, gender, and urge to smoke. Pain threshold and
tolerance times, and ratings of pain intensity were examined to determine whether the
pain manipulation was equivalent for the SC and NC conditions, and to determine
whether magnitude of pain reactivity was correlated with urge ratings within the P
conditions. Gender was tested as a potential moderator of the observed group
differences in urge to smoke. Because pain threshold and tolerance variables were
significantly positively skewed (pain threshold skewness = 2.87, pain tolerance
skewness = 1.96), we performed logarithmic transformations. One male participant was
treated as an outlier and excluded from the analysis because he obtained a tolerance
score (305s) that was greater than three standard deviations from the mean. As
expected based on prior research, we found significant gender differences in pain
threshold and tolerance times. Specifically, men demonstrated greater pain threshold
times than women, M = 11.59s (SD = 8.19s) vs. M = 5.98s (SD = 2.72s); t(63) = 4.65, p
< .001. Men also demonstrated greater pain tolerance times than women, M = 21.92s
(SD = 11.86s) vs. M = 15.718s (SD = 7.89s); t(63) = 2.69, p < .01. However, gender did
not moderate the observed group differences in urge to smoke following the pain
manipulation (p = .92). There were also no differences in ratings of pain intensity or
threshold and tolerance times as a function of cue type (SC vs. NC), indicating that the
pain manipulation was equivalent across these conditions (ps > .75). Finally, magnitude
of pain reactivity (i.e., ratings of pain intensity, and pain threshold and tolerance times)
was not correlated with urge to smoke within the P conditions.
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Discussion
The main goal of this study was to determine whether situational pain was
sufficient to increase smoking motivation, as indexed by self-reported urge to smoke and
observation of immediate smoking behavior. As hypothesized, participants who
experienced situational pain reported significantly greater smoking urges and
demonstrated shorter latency to smoke following experimental pain induction than
participants who did not experience pain.
As reviewed earlier, almost all research into the relationship between tobacco
use and chronic pain has focused on the effects of smoking on pain (i.e., smoking
exacerbating underlying pain conditions or smoking inhibiting acute episodes of pain).
An alternative approach within this line of research is to examine the effects of pain on
smoking. For example, the obvious health implications of smoking causing or
exacerbating chronic pain could only be compounded if smokers are at risk for
increasing their smoking behavior when experiencing periods of heightened pain
intensity. Some cross-sectional evidence does indicate that smokers with chronic pain
report a need to smoke when in pain, and this study provides the first experimental
evidence that situational pain is a causal motivator of smoking. By integrating these two
research directions, comprising the literature to date, we conceptualize a potentially
reciprocal relationship between pain and smoking. As illustrated in Figure 1, we propose
that smokers who are motivated to use tobacco to cope with or assuage pain may
unwittingly aggravate their painful condition by increasing their cigarette consumption,
thus engendering a vicious cycle that could lead to greater nicotine dependence.
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Figure 1. Conceptualization of the proposed reciprocal relationship between pain and smoking
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Interestingly, the demonstrated causal relationship between pain and enhanced
smoking motivation was only partially mediated by pain-induced state-negative affect.
This finding suggests that pain may be a potent motivator of smoking, mostly
independent of putative mood effects (i.e., increased negative affect). Indeed,
approximately 70% of the variance in the direct effect of pain induction on increased
urge to smoke remains unexplained. It is plausible that this relationship may also be
partially mediated by other psychological or physiological factors that were not detected,
measured, or manipulated in the current study such as the activation of smoking-related
or pain-related self-efficacy and outcome expectancies and the execution of pain-related
coping behaviors.
Although several potential moderators of the relationship between pain and
increased smoking motivation were explored, no significant interactions were revealed.
Cognitive variables such as expectancies that smoking reduces pain and the tendency
to catastrophize about pain did not predispose our participants toward smoking when in
pain. It may be that the processes measured by these instruments do not apply as well
to artificially-induced acute pain as compared to recurring chronic pain. That is, among
smokers who rarely need to cope with pain, as in the present sample, the questions may
have been too hypothetical. A chronic pain sample might produce different findings.
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Additionally, these measurements may be more valid when collected during periods of
acute pain.
Our finding that men evidenced greater pain threshold and tolerance times than
women is in accord with previous research that consistently demonstrates significant
pain-related gender differences (Berkley, 1997; Girdler et al., 2005; Myers, Riley, &
Robinson, 2003). However, we observed no significant gender differences in urge to
smoke following pain-induction, suggesting that although gender may play an important
role in pain reporting, exposure to a painful experience may be sufficient to increase
smoking urge regardless of whether the smoker is male or female. The lack of an
association between indices of pain reactivity and urge ratings within the pain induction
conditions, suggests that – at least with respect to the cold-pressor paradigm – there is
not a dose-response effect of pain. That is, acute pain produced increased urges to
smoke regardless of the perceived pain magnitude.
We also explored whether the presence and availability of smoking cues (versus
neutral cues) would interact with pain upon outcomes related to smoking motivation.
Although the pain by cue type interactions did not reach significance, urge ratings were
significantly higher in the presence of smoking cues relative to neutral cues. This finding
indicates additive, not synergistic, effects of pain and smoking cues on self-reported
urge to smoke. Latency to smoke, however, was not shorter in the presence of smoking
cues, perhaps suggesting that the painful experience overwhelmed the influence of cue
type once participants were given the opportunity to smoke a cigarette.
The main limitation of the current study is that these findings do not necessarily
generalize to individuals who suffer from chronic pain. Although the cold-pressor method
of pain stimulation may share some subjective qualities frequently observed in clinical
pain patients (Keogh et al., 2000; Rainville et al., 1992), there is no question that
23

experimentally-induced acute pain is not equivalent to the daily pain endured by people
with chronic conditions. However, we felt that subjecting chronic pain patients to
experimental pain induction at this early stage of hypothesis testing was unnecessary
and possibly inappropriate. In addition to ethical concerns, a laboratory pain paradigm
was selected to allow for increased experimental control and enhanced feasibility. A
second limitation is the potential influence of demand effects. Whereas it is conceivable
that participants may have recognized that self-reported urges to smoke were
hypothesized to increase following pain induction, it is more difficult to attribute the
observed group differences on the behavioral measure of smoking motivation (i.e.,
latency to smoke) to demand effects. A third limitation of the current findings is the
limited power to detect significant moderator interactions. Although we only intended to
examine the influence of potential moderating variables in an exploratory manner, future
investigations may benefit from focusing on this aspect of the casual association
between pain and smoking motivation to help elucidate important underlying
mechanisms. Indeed, some potential moderating variables (e.g., coping behaviors; selfefficacy and outcome expectancies) could be tested via experimental manipulation.
Future studies could also examine the potential for a dose-response relationship
between pain and smoking motivation. For example, one investigation of the relationship
between cold-pressor water temperature and pain tolerance and intensity concluded that
small reductions in water temperature resulted in significantly reduced tolerance times
and increased ratings of pain intensity (Mitchell et al., 2004). It would be interesting to
know if smoking motivation increased as a function of pain intensity or duration of the
painful experience. Another possibility is to examine differences in pain-induced smoking
motivation as a function of pain modality (e.g., cold pressor, thermal heat, electrical
stimulation, tourniquet ischemia), some of which may be closer analogues to chronic
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pain. Indeed, the nature of the noxious stimulus used to induce pain has been shown to
impact pain sensitivity (Girdler et al., 2005; Rainville et al., 1992). Finally, future research
should investigate the temporal relationship between pain and smoking motivation in
naturalistic (i.e., real-world) settings, perhaps using ecological momentary assessment
(Stone & Shiffman, 1994).
In summary, this study provides the first experimental evidence that situational
pain is a potent motivator of smoking, partially mediated by pain-induced negative affect.
That smokers are motivated to use tobacco in response to pain raises the possibility that
smokers with painful conditions could develop unique dependence profiles. We believe
that a systematic analysis of the causal link between pain and smoking motivation is an
appropriate next step in this line of research. Smoking appears to be a prominent feature
of painful conditions, and tobacco dependence may provide an invaluable model for
research on addictive behaviors in the chronic pain population.
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Appendix A: Smoking Status Questionnaire
1.

Date of Birth:______/______/______
Month Day
Year

2.

Sex: (check one)

3.

Do you smoke cigarettes everyday?
□ Yes
If No, stop here; If Yes, please continue

4.

How many years have you been smoking daily?_________

5.

How many cigarettes do you smoke per day on average?_________

6.

Do you inhale? (circle one)

7.

Do you smoke more during the first two hours of the day than during the rest of
the day? □ Yes
□ No

8.

How soon after you wake up do you smoke your first cigarette?
□ Within 5 minutes
□ 6-30 minutes
□ 31-60 minutes
□ After 60 minutes

9.

Which of all the cigarettes you smoke would you most hate to give up?
□ The first one in the morning
□ The one with breakfast
□ The one with lunch
□ The one with dinner
□ The last cigarette before going to bed
□ Other:_________________________

□ Male

□ Female

NEVER

□ No

SOMETIMES

ALWAYS

10. Do you find it difficult to refrain from smoking in places where it is forbidden
(eg. in church, at the library)? □ Yes
□ No
11. Do you smoke if you are so ill that you are in bed most of the day?
□ Yes
□ No
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Appendix B: Questionnaire of Smoking Urges-Brief
Indicate how much you agree or disagree with each of the following statements by marking one of
the circles between STRONGLY DISAGREE and STRONGLY AGREE. The closer you place
your mark to one end or the other indicates the strength of your agreement or disagreement. We
are interested in how you are thinking and feeling right now as you are filling out the
questionnaire.
1. I have a desire for a cigarette right now.
STRONGLY
DISAGREE

O

O

O

O

O

O

STRONGLY
AGREE

O

O

O

O

STRONGLY
AGREE

O

O

O

O

STRONGLY
AGREE

O

2. Nothing would be better than smoking a cigarette right now.
STRONGLY
DISAGREE

O

O

O

3. If it were possible, I probably would smoke now.
STRONGLY
DISAGREE

O

O

O

4. I could control things better right now if I could smoke.
STRONGLY
DISAGREE

O

O

O

O

O

O

O

STRONGLY
AGREE

O

O

O

O

O

STRONGLY
AGREE

O

O

O

O

O

STRONGLY
AGREE

O

O

O

O

STRONGLY
AGREE

O

O

O

O

STRONGLY
AGREE

O

O

O

O

STRONGLY
AGREE

O

O

O

O

STRONGLY
AGREE

5. All I want right now is a cigarette.
STRONGLY
DISAGREE

O

O

6. I have an urge for a cigarette.
STRONGLY
DISAGREE

O

O

7. A cigarette would taste good right now.
STRONGLY
DISAGREE

O

O

O

8. I would do almost anything for a cigarette now.
STRONGLY
DISAGREE

O

O

O

9. Smoking would make me less depressed.
STRONGLY
DISAGREE

O

O

O

10. I am going to smoke as soon as possible.
STRONGLY
DISAGREE

O

O

O
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Appendix C: Visual Analogue Scale (VAS)
Instructions: Please place an up-and-down line (“|”) on the scale where you feel it best
represents how you feel right now, at this very moment.

How strong is your urge to smoke a cigarette is AT THIS EXACT MOMENT?

No Urge
At All

Strongest
Urge Ever
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Appendix D: Smoking Consequences Questionnaire - Adult
Instructions: This questionnaire is designed to assess beliefs people have about the consequences of smoking a
cigarette. Below is a list of statements about smoking. We would like you to rate how LIKELY or UNLIKELY you believe
each consequence is for you when you smoke. If the consequence seems UNLIKELY to you, circle a number from 0-4. If
the consequence seems LIKELY to you, circle a number from 5-9. That is if you believe the consequence would never
happen, circle 0; if you believe a consequence would happen every time you smoke, circle 9. Use the guide below to aid
you further. For example, if a consequence seems completely likely to you, you would circle 9. If it seems a little unlikely
to you, you would circle 4.
0

1

2

3

4

5

6

7

8

9

Completely

Extremely

Very

Somewhat

A Little

A Little

Somewhat

Very

Extremely

Completely

UNLIKELY

LIKELY

1. Cigarettes help me deal with anxiety or worry.

0

1

2

3

4

5

6

7

8

9

2. Smoking would ease my pain if I were hurting.

0

1

2

3

4

5

6

7

8

9

3. Nicotine “fits” can be controlled by smoking.

0

1

2

3

4

5

6

7

8

9

4. When I’m angry, a cigarette can calm me down.

0

1

2

3

4

5

6

7

8

9

5. I become more addicted the more I smoke.

0

1

2

3

4

5

6

7

8

9

6. If I were to experience pain, a cigarette would help reduce it.

0

1

2

3

4

5

6

7

8

9

7. If I’m tense, a cigarette helps me to relax.

0

1

2

3

4

5

6

7

8

9

8. Smoking a cigarette energizes me.

0

1

2

3

4

5

6

7

8

9

9. Cigarettes help me deal with anger.

0

1

2

3

4

5

6

7

8

9

10. If I hurt myself, I would feel less pain if I could smoke.

0

1

2

3

4

5

6

7

8

9

11. Smoking calms me down when I feel nervous.

0

1

2

3

4

5

6

7

8

9

12. I feel like I do a better job when I am smoking.

0

1

2

3

4

5

6

7

8

9

13. A cigarette can give me energy when I’m bored and tired.

0

1

2

3

4

5

6

7

8

9

14. Cigarettes can really make me feel good.

0

1

2

3

4

5

6

7

8

9

15. When I’m feeling happy, smoking helps keep that feeling.

0

1

2

3

4

5

6

7

8

9

16. When I feel pain, a cigarette can really help.

0

1

2

3

4

5

6

7

8

9

17. Smoking will satisfy my nicotine cravings.

0

1

2

3

4

5

6

7

8

9

18. Cigarettes help me reduce or handle tension.

0

1

2

3

4

5

6

7

8

9

19. I feel better physically after having a cigarette.

0

1

2

3

4

5

6

7

8

9

20. A cigarette can satisfy my urge to smoke.

0

1

2

3

4

5

6

7

8

9

21. If I hurt myself, I could cope with the pain without smoking.

0

1

2

3

4

5

6

7

8

9

22. If I’m feeling irritable, a smoke will help me relax.

0

1

2

3

4

5

6

7

8

9

23. I will become more dependent on nicotine if I continue smoking.

0

1

2

3

4

5

6

7

8

9

24. When I am upset with someone, a cigarette helps me cope.

0

1

2

3

4

5

6

7

8

9

25. I feel like smoking would help me cope with pain.

0

1

2

3

4

5

6

7

8

9

26. I like the way a cigarette makes me feel physically.

0

1

2

3

4

5

6

7

8

9

27. When I am worrying about something, a cigarette is helpful.

0

1

2

3

4

5

6

7

8

9

28. Smoking temporarily reduces those repeated urges for cigarettes.

0

1

2

3

4

5

6

7

8

9
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Appendix E: PANAS-W
This scale consists of a number of words that describe different feelings and emotions.
Read each item and then mark the appropriate answer in the space next to that word.
Indicate to what extent you felt this way during the past week. Use the following scale
to record your answers.
1
very slightly
or not at all

2
a little

3
moderately

4
quite a bit

5
extremely

______interested

______irritable

______distressed

______alert

______excited

______ashamed

______upset

______inspired

______strong

______nervous

______guilty

______determined

______scared

______attentive

______hostile

______jittery

______enthusiastic

______active

______proud

______afraid
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Appendix F: PANAS-I
This scale consists of a number of words that describe different feelings and emotions.
Read each item and then mark the appropriate answer in the space next to that word.
Indicate to what extent you feel this way at this moment. Use the following scale to
record your answers.
1
very slightly
or not at all

2
a little

3
moderately

4
quite a bit

5
extremely

______interested

______irritable

______distressed

______alert

______excited

______ashamed

______upset

______inspired

______strong

______nervous

______guilty

______determined

______scared

______attentive

______hostile

______jittery

______enthusiastic

______active

______proud

______afraid
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Appendix G: Pain Catastrophizing Scale
Everyone experiences painful situations at some point in their lives. Such
experiences may include headaches, tooth pain, joint or muscle pain. People are often
exposed to situations that may cause pain such as illness, injury, dental procedures or
surgery.
We are interested in the types of thoughts and feelings that you have when you
are in pain. Listed below are thirteen statements describing different thoughts and
feelings that may be associated with pain. Using the following scale, please indicate the
degree to which you have these thoughts and feelings when you are experiencing
pain.
0
not at all

1
to a slight
degree

2
to a moderate
degree

3
to a great
degree

When I’m in pain …
1. ______ I worry all the time about whether the pain will end.
2. ______ I feel I can’t go on.
3. ______ It’s terrible and I think it’s never going to get any better.
4. ______ It’s awful and I feel that it overwhelms me.
5. ______ I feel I can’t stand it anymore.
6. ______ I become afraid that the pain will get worse.
7. ______ I keep thinking of other painful events.
8. ______ I anxiously want the pain to go away.
9. ______ I can’t seem to keep it out of my mind.
10. ______ I keep thinking about how much it hurts.
11. ______ I keep thinking about how badly I want the pain to stop.
12. ______ There’s nothing I can do to reduce the intensity of the pain.
13. ______ I wonder whether something serious may happen.
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4
all the time

Appendix H: NRS Measure of Pain Intensity
Please put a circle around the number that best describes your pain, at its worst,
since placing your hand in the water.
*Note: 0 means ‘No pain’ and 10 means ‘Pain as bad as you can imagine’
No pain

0

1

2

3

4

5

6
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7

8

9

10

Pain as bad
as you can
imagine

